✦ LIBER ✦

Erlotinib plus gemcitabine prolongs survival in pancreatic cancer

Book ID: 120855510
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2004
Weight: 120 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200414580-00010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased Survival in Pancreatic Cancer

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

✍ Von Hoff, Daniel D.; Ervin, Thomas; Arena, Francis P.; Chiorean, E. Gabriela; In 📂 Article 📅 2013 🏛 Massachusetts Medical Society 🌐 English ⚖ 637 KB

Erlotinib + gemcitabine of no value in p

Erlotinib + gemcitabine of no value in pancreatic cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Phase II study of erlotinib plus gemcita

Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer

✍ Takuji Okusaka; Junji Furuse; Akihiro Funakoshi; Tatsuya Ioka; Kenji Yamao; Shin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Gemcitabine versus gemcitabine plus dalt

Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer

✍ A. Maraveyas; J. Waters; R. Roy; D. Fyfe; D. Propper; F. Lofts; J. Sgouros; E. G 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 607 KB

Capecitabine + erlotinib for gemcitabine

Capecitabine + erlotinib for gemcitabine-refractory metastatic pancreatic cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

A phase II study of bevacizumab plus erl

A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer

✍ Andrew H. Ko; Alan P. Venook; Emily K. Bergsland; R. Kate Kelley; W. Michael Kor 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 266 KB